Tarbox Family Office’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-185
Closed -$15K 622
2016
Q4
$15K Buy
185
+9
+5% +$714 0.01% 221
2016
Q3
$14K Buy
176
+6
+4% +$484 0.01% 217
2016
Q2
$13K Hold
170
0.01% 220
2016
Q1
$9K Sell
170
-5
-3% -$272 0.01% 267
2015
Q4
$11K Sell
175
-4
-2% -$252 0.01% 224
2015
Q3
$11K Buy
179
+14
+8% +$999 0.01% 225
2015
Q2
$12K Hold
165
0.01% 214
2015
Q1
$11K Hold
165
0.01% 234
2014
Q4
$11K Hold
165
0.01% 237
2014
Q3
$10K Buy
165
+25
+18% +$1.63K 0.01% 244
2014
Q2
$9K Hold
140
0.01% 249
2014
Q1
$9K Hold
140
0.01% 268
2013
Q4
$9K Buy
+140
New +$8.11K 0.01% 298

Other funds holding STJ

Tarbox Family Office's STJ Position: Q1 2017 in Review

Tarbox Family Office sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 185 shares — an estimated $15K sold.

Tarbox Family Office first reported a position in STJ in Q4 2013 and held it in 13 quarters. The position peaked at $15K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Tarbox Family Office reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Tarbox Family Office sold 185 St Jude Medical shares in Q1 2017, an estimated $15K.
  • Tarbox Family Office first reported a position in St Jude Medical in Q4 2013 and held it in 13 quarters.
  • Tarbox Family Office's St Jude Medical position peaked at $15K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Tarbox Family Office's 13F filing for Q1 2017, filed 28 Apr 2017.